Identifying Patterns and Barriers in OncotypeDX Recurrence Score Testing in Older Patients With Early-Stage, Estrogen Receptor-Positive Breast Cancer: Implications for Guidance and Reimbursement.
Dario TrapaniQingchun JinCaroline C BlockRachel A FreedmanNancy U LinPaolo TarantinoElizabeth A MittendorfTari A KingSusan C LesterJane E BrockNabihah TayobCraig A BunnellSara M TolaneyHarold J BursteinPublished in: JCO oncology practice (2023)
Internal guidelines may facilitate standardized utilization of the RS in early-BC. Our data suggest that clinicians preferred broader utilization of RS across the age spectrum, with therapeutically important consequences. Modifying the current policy for reimbursement of RS testing and in internal reflexive testing criteria for those older than 65 years is warranted.